A Phase II Study of Enhancing Anti-Tetanus Vaccine Response After Autologous Stem Cell Transplantation
Categories (click each to see list of all clinical trials associated with that category): Myeloma/Plasma Cell Dyscrasia
Current Status: Open to accrual
Phase: II
Principal Investigator: D'Angelo, Christopher
Contact Information:
Amberley Proctor
+1 402-836-9171
amberley.proctor@unmc.edu
Eligibility: https://www.clinicaltrials.gov/ct2/show/NCT02700841?cond=NCT02700841&draw=2&rank=1#eligibility
Summary